Article
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk…
medRxiv · 2023 · Florian Märkl, author Christoph Schultheiß, author Murtaza Ali, author Shih-Shih Chen, author Lukas Egli, author Juliane Mietz, author Obinna Chijioke, author Lisa Paschold, author Sebastijan Spajic, author Anne Holtermann, author Janina Dörr, author Sophia Stock, author Ignazio Piseddu, author David Anz, author Marcus Dühren-von Minden, author Tianjiao Zhang, author Thomas Nerreter, author Michael Hudecek, author Nicholas Chiorazzi, author Sebastian Kobold, author Mascha Binder, author
Key facts
| Title | Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia |
|---|---|
| First author | Florian Märkl, author Christoph Schultheiß, author Murtaza Ali, author Shih-Shih Chen, author Lukas Egli, author Juliane Mietz, author Obinna Chijioke, author Lisa Paschold, author Sebastijan Spajic, author Anne Holtermann, author Janina Dörr, author Sophia Stock, author Ignazio Piseddu, author David Anz, author Marcus Dühren-von Minden, author Tianjiao Zhang, author Thomas Nerreter, author Michael Hudecek, author Nicholas Chiorazzi, author Sebastian Kobold, author Mascha Binder, author |
| Journal | medRxiv |
| Published | Oct 4, 2023 |
| DOI | 10.1101/2023.09.29.560075 |
| Devices mentioned | K103302 |
| Product codes mentioned | MVU, NJT, OOI, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1